Osage Partners

Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals and Nutritionals. - The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). - The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

InstaMed powers a better healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumer satisfaction. It was formed in 2004 and headquartered in Philadelphia, Pennsylvania.

Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.

Developer of a cloud-based drone operational platform designed to support commercial entities for launching and managing commercial drone operations. The company's platform offers flight planning, airspace management, data analytics, compliance, drone management, resource management and maintenance information in a singular platform, enabling drone operators and service providers to have access to the command and control for one or multiple unmanned aerial vehicle (UAV) operations at any given time.

Developer of a decentralized identity platform designed to provide software as a service. The company's platform has a full-stack verifiable credential and digital wallet that uses digital credentials based on open standards that can be integrated into the existing system as well as offers custom services, enabling users and organizations with digital identity and safety.

Automated Insights is a provider of content automation services. It is the creator of Wordsmith, the world’s first public natural language generation template engine. Wordsmith allows users to generate human-sounding narratives from data, making it easy to produce millions of personalized reports, articles, and narratives in the time it takes to write just one. The Wordsmith platform helps companies in data-driven industries, including financial services, e-commerce, real estate, business intelligence, media, and many others, achieve content scale, efficiency, and personalization. More than 200 customers, including Allstate, The Associated Press, Edmunds.com, the Orlando Magic, and Yahoo! use Wordsmith to generate more than 1.5 billion pieces of content per year.

Menlo Security provides a cloud-based isolation platform that protects organizations from cyberattacks by eliminating the threat of malware from websites, documents, and emails. Menlo Security is trusted by major global businesses, including Fortune 500 companies and financial services institutions, and backed by Vista Equity Partners, Neuberger Berman, General Catalyst, Sutter Hill Ventures, Engineering Capital, Osage University Partners, American Express Ventures, Ericsson Ventures, HSBC, and JP Morgan Chase. Menlo Security was founded in 2012 and headquartered in Mountain View, California.

AppBus provides a digital business platform that integrates, automates and secures enterprise application delivery to any device on any network. With AppBus, acclimating to change is simple, we leverage the capabilities of the enterprise, enable transparency for automation and accelerate the delivery of optimal experiences. Our platform ensures innovation and time to value throughout the enterprise ecosystem with employees, customers, and partners.

Brimstone Energy is a hardware cleantech startup that aims to reduce CO2 emissions through innovative technologies.

DrayNow is the first real-time marketplace for matching intermodal freight and carriers. The company's intermodal marketplace uses technology to connect intermediaries to more carriers on short notice, maintain visibility of the shipment's location and status at all times, and helps truckers to compare rates, view load details, and select available loads in their area in real-time, enabling companies in the intermodal industry to operate with increased efficiency in order to maintain optimal levels of capacity, service, visibility, and profitability.

CIPIO Inc. develops a customer intelligence platform for B2C businesses. It offers CIPIO that democratizes hyper-personalized predictions and recommendations throughout the customer journey. The company’s CIPIO that operates as a domain-infused intelligent assistant to identify the right customers, products, channels, and offers to improve engagement and wallet share across the customer journey. The company was incorporated in 2019 and is based in Fairfax, Virginia with additional offices in Redwood City, California; and Bengaluru and Ahmedabad, India.

Corelight, Inc. provides network visibility solutions for information security professionals. It offers Corelight sensors; Corelight fleet manager; software products; and solutions to secure networks for enterprises, government, and higher education sectors. The company also provides open-source Bro, an open source network analysis framework that generates actionable, real-time data for various security teams worldwide. Corelight, Inc. was founded in 2013 and is based in San Francisco, California. It has additional offices in San Francisco and Santa Clara, California; and Columbus, Ohio.

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Interius BioTherapeutics is a biopharmaceutical company that targets cancer. The company spun out the University of Pennsylvania and is targeting cancer.

SiFive designs chips for the semiconductor industry. It offers the system on a chip for the microcontroller, embedded, IoT, and wearable applications; and toolset to provide debug capabilities. SiFive brings the power of open source and software automation to the semiconductor industry, making it possible to develop new hardware faster and more affordably than ever before. With our platform for rapidly designing, testing, and building RISC‑V-based core IP and chips, we’re accelerating the pace of innovation for businesses large and small.

DeepSurface Security (www.deepsurface.com) is the first automated Predictive Vulnerability Management suite of tools that helps cybersecurity teams automate the process of analyzing and prioritizing vulnerabilities by risk contribution on enterprise networks. Created by a veteran cybersecurity team, DeepSurface Security is trusted by enterprise companies to identify, prioritize, and research vulnerabilities in their networks. Headquartered in Portland, Oregon, DeepSurface is a privately held company funded by Cascade Seed Fund, SeaChange Fund, and Voyager Capital. To learn more visit www.deepsurface.com.

Nikola Labs LLC is a wireless power company that develops technology to convert radio frequency (RF) energy into direct current (DC) power for electronic devices. Its technology converts RF signals, such as Wi-Fi, Bluetooth, and LTE into DC power that is ideal for low-power wireless sensors. The company was founded in 2014 and is based in Columbus, Ohio.

Halfpenny Technologies, Inc. develops cloud-based healthcare interoperability solutions. It provides clinical data exchange solutions, orders management and computerized provider order entry solutions, business intelligence and notification solutions, and clinical data services. The company’s cloud-based solutions offers vendor-neutral infrastructure that supports care coordination, care management, regulatory requirements, and data analysis within and between healthcare organizations. It serves health plans, accountable care organizations, hospitals, radiology centers, pharmacies, commercial laboratories, population health, care coordination vendors, and HIEs in the United States. The company was founded in 2000 and is based in Blue Bell, Pennsylvania. As of June 14, 2019, Halfpenny Technologies, Inc. operates as a subsidiary of Accumen.

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR's novel approach provides a real opportunity to bring innovative new medicines to patients in need.

Verge Aero (Verge) is a Philadelphia-based team of electrical, computer, software, systems, and aerospace engineers, whose mission is focused on building and deploying unmanned aerial systems (UASs), or drones, for use in the entertainment industry. Verge has designed, developed, and implemented a drone performance software capable of controlling swarms of drones and integrating into existing entertainment systems, providing dynamic interactions with audiences and actors. Near-term applications of the technology include recurring drone performances, venue installations, touring drone performance productions, and drone entertainment products.

Katabat™ enables digital transformation with complete visibility across the consumer lifecycle. Experience our unified platform that increases customer satisfaction and retention, at a lower cost. Whether you are a servicer, lender, retailer, or utility, our SaaS solutions create an outstanding on-demand experience while driving security, compliance, and revenue. Katabat was founded by financial and technology industry experts, so we fully understand your security and compliance needs. Data security is part of our culture, and you can see that in our platform’s uncompromising security standards. Katabat™ is a PCI Level 1 Service Provider and your data is encrypted using the most secure F5 firewalls. https://katabat.com/our-story/

Connected2Fiber helps the network industry transact and improve its return on marketing investment with the industry’s only SaaS marketplace enablement platform that combines Account Based Marketing, Location Intelligence with predictive algorithms that learns how to improve results. The platform helps network owners and network buyers improve transparency, speed and effectiveness with information, automation and predictive algorithms. Connected2Fiber is based in Hopkinton, MA, and was founded in 2015 by Ben Edmond. The Connected World was built to provide a better way to view, share, manage, learn and engage at a location level for networks.

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and various neurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.

Kolltan Pharmaceuticals, Inc., is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.

Modis Therapeutics, Inc. develops disease modifying therapies for rare genetic diseases. The company designs and develops a therapy MT1621, which restores mitochondrial DNA replication fidelity. The company was incorporated in 2016 and is based in Oakland, California. As of September 6, 2019, Modis Therapeutics, Inc. operates as a subsidiary of Zogenix, Inc..

DiCE Molecules Corp. develops a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Its technology allows the extension of directed evolution to provide organic compounds as the output. The company also develops a methodology for translating DNA encoded information directly into organic compounds in essence roboticizing the laborious processes of medicinal chemistry. Its technology is used in the fields of pharmaceuticals, agriculture, and materials sciences. DiCE Molecules Corp. was incorporated in 2013 and is based in Menlo Park, California.

Vector was founded by several members of the original SpaceX team and is a disruptive innovator that connects space startups with affordable and frequent launch and platforms to enable space capabilities at a speed and price point never before possible. Vector has a big vision to reshape the 400 billion dollar space market by combining dedicated low-cost micro satellite launch and software defined satellites (Galactic Sky) to dramatically increase access and speed to orbit.

MC10, Inc. develops and sells wearable medical sensors for collecting medical grade, clinical quality bio-metric, and physiological data in a clinical trial setting. The company’s products include BioStamp nPoint, which collects and processes raw data into recognizable clinical metrics including vital signs, activity and posture classification, and sleep metrics; Kintinuum, a rehabilitation device for orthopedic surgery; WiSP, a cardiac monitoring and electrocardiographs (ECG) recording solution; and BioStampMD, a wearable sensor conforming to the human body to collect objective and patient-reported subjective data. It sells its products online. The company was founded in 2008 and is based in Lexington, Massachusetts.

GoCanvas is a mobile platform that makes it simple for any business to automate how work is done, replacing outdated processes and expensive paperwork. The GoCanvas App works on all smartphones and tablets, helping companies easily collect information across their organization, share it instantly with others, and gain real-time insights on their business operations. It was founded in 2008 and headquartered in Reston, Virginia.

At Identropy, we’re OCD about making customers successful in their Identity Management initiatives. It has been our sole focus since our founding in 2006, and most of us have over 10 years of experience in this space. While we’ve had the privilege of making many clients successful, we’ve also seen firsthand how difficult these programs can be to implement and to sustain. We believe that cloud computing provides the platform that can truly revolutionize how IDM solutions are delivered and consumed, and bring to fruition the vision of better security, lowered costs, and fast time-to-value.

Algorithmia, Inc. provides the infrastructure that enables algorithm developers to explore, create, and share algorithms as Web services. The company helps its clients deploy models into production by creating a versioned, scalable API (application program interface) endpoint any application or model can call. The company's product helps clients work on Tensorflow, PyTorch, Scikit-learn, and MXNet. Algorithmia, Inc. was founded in 2013 and is based in Seattle, Washington.

Ribon Therapeutics, Inc. operates as biotechnology company, which develops therapeutics novel enzymes for cancer medicines. The company was incorporated in 2015 and is based in Lexington, Massachusetts.

DrayNow is the first real-time marketplace for matching intermodal freight and carriers. The company's intermodal marketplace uses technology to connect intermediaries to more carriers on short notice, maintain visibility of the shipment's location and status at all times, and helps truckers to compare rates, view load details, and select available loads in their area in real-time, enabling companies in the intermodal industry to operate with increased efficiency in order to maintain optimal levels of capacity, service, visibility, and profitability.

Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.

Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. They are now Antiva Biosciences which is headquartered in South San Francisco.

Malbec Solutions, Inc. offers contract management and quote management solutions and software for industries. It offers Malbek CONTRAX and Malbek PLAYBOOK. Malbek CONTRAX offers contract redlining, negotiation, review, repository, contract request and authoring, clause library, e-signature execution, contract commitment tracking, contract insights and encryption. Malbek PLAYBOOK provides pre-deal analysis, products and services blending and profitability analysis. The company serves technology and services, manufacturing, industrial gas, government, life sciences and consumer goods industries. The company was founded in 2017 and is based in Somerset, New Jersey.

ProtonMedia, Inc. provides e-learning solutions. The company develops ProtoSphere, a business collaboration software that allows organizations to create a 3D environment optimized for business applications, such as e-learning and virtual meetings, as well as virtual conference events, scientific research and development, and sales and manufacturing collaborations involving rich data visualization. It serves clients in pharmaceuticals, medical devices, financial services, and technology worldwide. ProtonMedia, Inc. was founded in 1998 and is based in Lansdale, Pennsylvania.

Developer of an all-in-one commerce & content platform designed to serve as a bridge between existing Web2 services and the Web3 ecosystem. The company's platform helps the creator turn their personal website into a creative library & digitally-native commerce platform, and expands the accessibility of Web3 to all creators, enabling them to build an interactive website, portfolio, or link-in-bio in minutes for every drop.

Menlo Security provides a cloud-based isolation platform that protects organizations from cyberattacks by eliminating the threat of malware from websites, documents, and emails. Menlo Security is trusted by major global businesses, including Fortune 500 companies and financial services institutions, and backed by Vista Equity Partners, Neuberger Berman, General Catalyst, Sutter Hill Ventures, Engineering Capital, Osage University Partners, American Express Ventures, Ericsson Ventures, HSBC, and JP Morgan Chase. Menlo Security was founded in 2012 and headquartered in Mountain View, California.

Transeo is a cloud-based educational solution that helps students and administrators track, report, and celebrate their community service learning experiences. We make hour verification, logging, and report generation easy for students and counselors. We are helping schools and districts move away from paper-based processes so counselors can invest more quality time with the people who matter the most: students.

ReCode Therapeutics is a development-stage biopharmaceutical company focused on the correction of the nonsense mutations that account for 1/3 of all inherited diseases, including approximately 10% of cystic fibrosis. They have combined selected tRNAs with their unique and diverse proprietary delivery platforms to create and develop first-in-class suppressor tRNA-nanoparticle therapeutics for correcting nonsense mutations. ReCode’s diverse pipeline includes lead programs for primary ciliary dyskinesia (PCD) and nonsense mutations in cystic fibrosis (CF). The company’s proprietary non-viral lipid nanoparticle platform enables the delivery of a variety of payloads, and precise organ targeting of nucleic acid and protein payloads via both systemic and local delivery. ReCode is leveraging its nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated protein replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. The company was founded in 2015 and is based in Dallas, Texas.

Vizual.ai is an A.I. content imagery optimization platform that integrates with publisher web pages to drive increased user engagement. The Vizual.ai platform automatically deploys static images and .gif formats for any site imagery including video thumbnails and text based content, increasing publisher click through rates and site monetization. Vizual.ai is the first company to launch from Foundry.ai, the artificial intelligence studio created by industry veterans Jim Manzi and Ned Brody.

Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.

Escient Pharmaceuticals, Inc., a biotechnology company, develops and manufactures G protein-coupled receptor (GPCR)-targeted drugs for treating neuro-immuno-inflammatory and autoreactive diseases. The company focuses on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs) for neuro-immuno-inflammatory and autoreactive diseases. Escient Pharmaceuticals, Inc. was formerly known as Mas Therapeutics, Inc. The company was founded in 2017 and is based in San Diego, California.

PMV Pharmaceuticals, Inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. Its lead product candidate is PC14586, a small molecule that corrects and restores p53 function. The company also develops product candidates for p53 R273H hotspot mutation and other p53 hotspot mutations. PMV Pharmaceuticals, Inc. was formerly known as PJ Pharmaceuticals, Inc. and changed to in July 2013. The company was founded in 2013 and is headquartered in Cranbury, New Jersey.

DiCE Molecules Corp. develops a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Its technology allows the extension of directed evolution to provide organic compounds as the output. The company also develops a methodology for translating DNA encoded information directly into organic compounds in essence roboticizing the laborious processes of medicinal chemistry. Its technology is used in the fields of pharmaceuticals, agriculture, and materials sciences. DiCE Molecules Corp. was incorporated in 2013 and is based in Menlo Park, California.

Hack The Box Ltd. operates an online platform to test and advance skills in penetration testing and cyber security for companies, individuals, and universities. The company was founded in 2017 and is based in Folkestone, United Kingdom.

Refraction AI, Inc., an autonomous delivery robot company, builds and deploys robotic platforms to provide goods delivery in urban areas. It offers The REV-1, a delivery robotic vehicle that picks up goods from restaurants, pharmacies, and grocery stores, and bring them directly to the customers’ house. Refraction AI, Inc. was founded in 2017 and is based in Ann Arbor, Michigan.

Egenesis Inc., a biotechnology company, operates as a gene editing and genome engineering that develops human transplantable organs, tissues, and cells. It offers a gene editing platform for developing human compatible organs. The company also provides development, such as gene engineering, single cell cloning, somatic cell nuclear/embryo transfer, organ procurement, and transplantation. The company was incorporated in 2015 and is based in Cambridge, Massachusetts with an additional office in New York, New York.

Hyalex Orthopaedics is a Lexington, MA medical device company advancing new products that feature HYALEX™ materials technology, a polymer that is designed to mimic cartilage. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics' products are in the development stage and have not been approved for use in humans by any regulatory agency.

Liquid Light Corporation develops and licenses process technology to make chemicals from carbon dioxide (CO2). Its technology is centered on low-energy catalytic electrochemistry to convert CO2 to multi-carbon chemicals. The company is developing process for the production of ethylene glycol. Liquid Light Corporation was incorporated in 2008 and is based in Monmouth Junction, New Jersey. As of January 10, 2017, Liquid Light Corporation operates as a subsidiary of Avantium Technologies B.V..

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.

RiskLens, Inc. provides cyber risk management software. It offers Cyber Risk Maturity, an applied maturity model that measures an organization’s ability to manage risk over time and its compliance against NIST CSF; Cyber Risk Triage, a rapid risk assessment tool that helps determine, which new cyber risk scenarios deserve a full risk analysis; Cyber Risk Third-Party, a risk assessment solution for organizations to assess the risk management practices of third parties, such as vendors, partners, cyber insurance buyers, or acquisition targets; Cyber Risk Quantification, a decision-support application that quantifies an organization's financial risk exposure to cyber security events; and standard value at risk model for cyber security and operational risk. The company also provides a suite of SaaS applications that enables chief information risk officers and chief information security officers to quantify and manage cyber risk from the business perspective; and empowers enterprises and government organizations to manage cyber risk. In addition, it offers professional services; factor analysis of information training and certification; and application training services. The company serves financial services, government, healthcare, education, and technology markets. RiskLens, Inc. was formerly known as CXOWare, Inc. The company was incorporated in 2011 and is based in Spokane, Washington.

Delfi Diagnostics detect cancer early, when it is most curable, using high precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. It was founded in 2019 and is headquartered in Baltimore, Maryland.

Artizan Biosciences, Inc. develops small molecule drugs for use in humans. The company use IgA-SEQ technology platform to distinguish disease-driving bacteria from the intestinal microbiota to developing new and potentially curative treatments. Artizan Biosciences, Inc. was founded in 2016 and is headquartered in New Haven, Connecticut.

Censys, Inc. provides internet scanning and asset identification solutions. It offers Censys, an internet device search engine for finding internet devices, such as computers, servers, and smart devices that hosts the data. The company’s Censys is used for attack surface management, search and API, home network risk identifier, and bulk internet data. Its solution is used in various use cases, such as discovering unknown assets, monitoring remote workforce, and identifying threat actors. The company was founded in 2017 and is based in Ann Arbor, Michigan.

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Luxtera, Inc., designs and builds front panel and embedded optical modules based on its silicon photonics technology for data centers and mobile infrastructure. Its products include faceplate pluggable optical transceivers and embedded optical transceiver. Luxtera, Inc. was founded in 2001 and is based in Carlsbad, California. As of February 6, 2019, Luxtera, Inc. operates as a subsidiary of Cisco Systems, Inc.

SiFive designs chips for the semiconductor industry. It offers the system on a chip for the microcontroller, embedded, IoT, and wearable applications; and toolset to provide debug capabilities. SiFive brings the power of open source and software automation to the semiconductor industry, making it possible to develop new hardware faster and more affordably than ever before. With our platform for rapidly designing, testing, and building RISC‑V-based core IP and chips, we’re accelerating the pace of innovation for businesses large and small.

HUED is a platform that diversifies the patient/doctor connection by connecting patients with diverse healthcare providers.

Pneuron overcomes the time, cost, and complexity challenges associated with traditional enterprise development, deployment and integration approaches. Using Pneuron’s Distributed Platform, organizations can leverage existing systems and infrastructure to connect data, applications, processes, and analytics without the need of intermediary databases, associated data integration costs or system replacement. In a single non-invasive “fabric” Pneuron allows the enterprise to manage the entire business solution lifecycle from a single screen – including development, deployment, integration, resiliency, availability and performance - freeing the enterprise to focus on realizing business value. The result is unprecedented productivity, engagement of business expertise, and reduced cost of success, inspiring new waves of innovation.

BA Insight develops integrated search technologies that help organizations enhance Microsoft SharePoint® usage

Earnest Research is a data innovation company driven to change the way professionals understand consumer and business behavior. Working with world-class data partners, we transform raw data into a source for business and investment professionals to ask better questions so they can make better decisions.

Indico Data Solutions, INC. develops an enterprise artificial intelligence-based solution for unstructured content process automation. Its platform enables enterprises to create customized machine learning models using smaller data sets and machine learning tools. Indico Data Solutions, INC. was founded in 2013 and is based in Boston, Massachusetts.

Menlo Security provides a cloud-based isolation platform that protects organizations from cyberattacks by eliminating the threat of malware from websites, documents, and emails. Menlo Security is trusted by major global businesses, including Fortune 500 companies and financial services institutions, and backed by Vista Equity Partners, Neuberger Berman, General Catalyst, Sutter Hill Ventures, Engineering Capital, Osage University Partners, American Express Ventures, Ericsson Ventures, HSBC, and JP Morgan Chase. Menlo Security was founded in 2012 and headquartered in Mountain View, California.

HelloTeam is a modern engagement and talent management platform, designed to increase employee engagement, impact retention and create data-driven people strategies backed by real-time instant insights and analytics. Our platform enables employees to be seen, heard and valued, leading to a more engaged, connected and inspired workforce.

Otonomy was founded in 2008 by Avalon Ventures and experts in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes and from these, three product candidates have been advanced into development.

BookKeeping Express combines technology and people to give small and medium businesses the full range of bookkeeping, management accounting, and financial reporting services that they can use to better understand and grow their businesses. As a national provider of complete financial transaction processing, including business bookkeeping, general ledger, payroll, bill pay, cash management, merchant services, and reporting, we have served the business community for more than 28 years. Between our experienced Team Center and our extended network of professionals, we are committed to bringing 21st century modernization to bookkeeping and small business processes.

DrayNow is the first real-time marketplace for matching intermodal freight and carriers. The company's intermodal marketplace uses technology to connect intermediaries to more carriers on short notice, maintain visibility of the shipment's location and status at all times, and helps truckers to compare rates, view load details, and select available loads in their area in real-time, enabling companies in the intermodal industry to operate with increased efficiency in order to maintain optimal levels of capacity, service, visibility, and profitability.

SolarBridge Technologies, formerly SmartSpark Energy Systems, was founded in 2004 to commercialize power electronics technologies created at the University of Illinois. In early 2009, they launched a new corporate strategy to focus exclusively on the solar industry with microinverter and monitoring solutions. The company has a major research and development site in Champaign, Illinois and has recently expanded to include a new corporate headquarters in Austin, Texas. Led by industry veterans and academic professionals, their mission is to reduce the Levelized Cost of Energy (LCOE) for solar installations by dramatically improving reliability, increasing energy production, and simplifying installation.

Redlasso is a web service that allows users to search TV and radio broadcasts, create clips and share them. On May 20, 2008, it was leaked that RedLasso had been [served](http://www.techcrunch.com/2008/05/20/bloggers-rejoice-customized-tv-clips-with-redlasso/) a Cease and Desist letter from a number of major media organizations. In response, the company [brought on](http://corp.redlasso.com/press/Redlasso-052908-01.pdf) Michael Jordan, former CEO of CBS and Westinghouse Corporation, as a senior advisor.

Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath™ Closed IV Catheter System, in 2012.

Provides infrastructure performance monitoring solutions for customers worldwide

Seismos Inc. provides real-time monitoring of oil wells during production that enables oil-field decision-making. The company was founded in 2013 and is based in Austin, Texas.

Vector was founded by several members of the original SpaceX team and is a disruptive innovator that connects space startups with affordable and frequent launch and platforms to enable space capabilities at a speed and price point never before possible. Vector has a big vision to reshape the 400 billion dollar space market by combining dedicated low-cost micro satellite launch and software defined satellites (Galactic Sky) to dramatically increase access and speed to orbit.

Neuros Medical, Inc., a neuromodulation company, develops proprietary neurostimulation therapies for unmet needs to patients worldwide. It offers Electrical Nerve Block, a technology for the elimination of chronic pain in various applications, including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine. The company also provides Neuros Altius System, a product that consists of an implantable generator with an integrated rechargeable battery, cuff electrode, and external devices. Neuros Medical, Inc. was incorporated in 2008 and is based in Willoughby Hills, Ohio.

Escient Pharmaceuticals, Inc., a biotechnology company, develops and manufactures G protein-coupled receptor (GPCR)-targeted drugs for treating neuro-immuno-inflammatory and autoreactive diseases. The company focuses on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs) for neuro-immuno-inflammatory and autoreactive diseases. Escient Pharmaceuticals, Inc. was formerly known as Mas Therapeutics, Inc. The company was founded in 2017 and is based in San Diego, California.

BA Insight develops integrated search technologies that help organizations enhance Microsoft SharePoint® usage

E-Scape Bio, Inc., a biopharmaceutical company, discovers and develops small molecule therapies to treat genetically defined subpopulations in neurodegenerative diseases. Its programs improve the lives of patients suffering from Alzheimer’s disease, Parkinson’s disease, and sphingolipid storage disorders. E-Scape Bio, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Skytree is a California-based software company that develops and publishes a machine learning platform for advanced analytics. The company offers a platform that gives organizations the power to discover analytic insights, predict future trends, make recommendations, and reveal untapped markets and customers. Backed by investments from US Venture Partners, Javelin Venture Partners, Samsung, UPS, and In-Q-Tel, Skytree is involved in enterprise-grade machine learning. The company was founded in 2012 by [Martin Hack](https://www.crunchbase.com/person/martin-hack) and [Alexander Gray](https://www.crunchbase.com/person/alexander-gray). It is headquartered in San Jose, C.A.

Everactive, Inc., doing business as Everactive Insights, Inc., develops wireless sensing devices and technologies to generate data for the analytics of Industrial IoT. It offers PsiKick ICs, a system-on-chip with sensor analog front-ends that are used for programmable processing and memory, power management, programmable hardware acceleration, and RF (wireless) communication applications across various frequencies. The company’s solutions include steam trap monitoring, flare system monitoring, and machine health monitoring. Everactive, Inc. was formerly known as PsiKick, Inc. and changed its name to Everactive, Inc. in June 2019. The company was founded in 2012 and is based in Santa Clara, California. It has locations in Charlottesville, Virginia; and Ann Arbor, Michigan.

Full Measure Education is a Student Lifecycle and Retention Management company developing a student-facing mobile/social/web technology and human-powered retention services that keep students from dropping out of college. Full Measure Education’s cutting edge approach and technology design is the result of lessons learned by its senior management through 10,000,000 plus student help desk interactions at 850 plus colleges and universities. As a result, Full Measure Education has more post-secondary experience with which to deliver extraordinary outcomes in every major benchmark, including retention, enrollment growth, operational efficiencies, and financial aid utilization.

Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath™ Closed IV Catheter System, in 2012.

Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company’s VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.

Artizan Biosciences, Inc. develops small molecule drugs for use in humans. The company use IgA-SEQ technology platform to distinguish disease-driving bacteria from the intestinal microbiota to developing new and potentially curative treatments. Artizan Biosciences, Inc. was founded in 2016 and is headquartered in New Haven, Connecticut.

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.

InstaMed powers a better healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumer satisfaction. It was formed in 2004 and headquartered in Philadelphia, Pennsylvania.

Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.

Ribon Therapeutics, Inc. operates as biotechnology company, which develops therapeutics novel enzymes for cancer medicines. The company was incorporated in 2015 and is based in Lexington, Massachusetts.

Everactive's custom ultra-low-power chips enable completely battery-less wireless sensors that form the foundation of end-to-end IoT data services. The company technology allows for low cost, long-lived, and intelligent instrumentation of industrial operations. Its end-to-end solutions are built upon innovative advances in ultra-low-power circuit design and wireless communication that enable the company to power its Eversensors exclusively from harvested energy. The company also creates networking and cloud software to provide a service focused on providing customers with valuable insights from generated and self-sustaining data streams. The company was founded on 2012 and is based in Santa Clara, California.

Blade Therapeutics is a discovery stage drug development company. Their mission is to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Their leadership team has extensive experience at developing drugs that treat fibrotic disorders. They are also partnering with international experts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.Cyteir Therapeutics is creating breakthrough solutions to the major challenges facing cancer researchers today. Currently in development, is the answer to the oncology triumvirate: reducing side effects, reducing therapy resistance, inducing diseased cell self destruction.

ProtonMedia, Inc. provides e-learning solutions. The company develops ProtoSphere, a business collaboration software that allows organizations to create a 3D environment optimized for business applications, such as e-learning and virtual meetings, as well as virtual conference events, scientific research and development, and sales and manufacturing collaborations involving rich data visualization. It serves clients in pharmaceuticals, medical devices, financial services, and technology worldwide. ProtonMedia, Inc. was founded in 1998 and is based in Lansdale, Pennsylvania.

InstaMed powers a better healthcare payment experience on one platform that connects consumers, providers, and payers for every healthcare payment transaction. InstaMed’s patented, private cloud-based technology securely transforms healthcare payments by driving electronic transactions, moving money, and healthcare data seamlessly, and improving consumer satisfaction. It was formed in 2004 and headquartered in Philadelphia, Pennsylvania.